Bird flu, Avian influenza, Diabetes, Cholesterol, Caner, HIV

Medical News Today - Diabetes (5 unread)

Retacrit Effective In Patients With Diabetic Nephropathy

Posted: September 8th, 2008, 4:00pm CDT

Hospira (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today presented new data showing Retacrit® (epoetin zeta) is as effective as epoetin alfa (Erypo®) in achieving and maintaining haemoglobin (Hb) levels in end-stage renal failure patients with diabetic nephropathy.1 The results from an analysis of two pivotal Phase III studies were presented at the annual meeting of the European Association for the Study of Diabetes (EASD).
Survey Helps Identify Strategies To Address Diabetes Care And Global Economic And Social Impact Of Type 2 Diabetes

Posted: September 8th, 2008, 7:00am CDT

Less than 50% of people with type 2 diabetes are estimated to be at or below their HbA1c [a] (blood sugar) target according to preliminary findings from the global Diabetes Impact Survey presented this week in conjunction with the 44th annual meeting of the European Association for the Study of Diabetes (EASD).
New Data From A Phase 3 Study Confirms Clinical Benefits Of Once-Daily Liraglutide In The Management Of Type 2 Diabetes

Posted: September 8th, 2008, 7:00am CDT

Data from a phase 3 clinical study (LEAD™ 4) presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD) demonstrated that adding the investigational new drug liraglutide, a human GLP-1 analogue, to metformin and rosiglitazone in the treatment of type 2 diabetes, leads to improved blood glucose lowering (HbA1c)1, weight loss, blood pressure reduction and improvement in beta cell functioning.
People With Diabetes Missing Out On Life Saving Medication, UK

Posted: September 8th, 2008, 6:00am CDT

One in four patients with diabetes are not receiving the appropriate cardiovascular medications, research launched at the British Pharmaceutical Conference (BPC) in Manchester has shown. Diabetes and its complications are responsible for an estimated one in 17 deaths in the UK(1). Cardiovascular complications such as heart disease and stroke are major causes of mortality and morbidity among diabetics.
Journal Of Clinical Investigation Online Early Table Of Contents: Sept. 5, 2008

Posted: September 8th, 2008, 4:00am CDT

VIROLOGY: HIV-stimulated immune cells generate cells with immunosuppressive properties Nina Bhardwaj and colleagues, at New York University, have provided new insight into the role of human immune cells known as plasmacytoid dendritic cells (pDCs) in the anti-HIV immune response. When pDCs interact with HIV they become activated, secreting large amounts of the soluble factor IFN-alpha, which is a key component of the anti-HIV immune response.

← September 7 (2 items) September 9 (10 items) →

My Health News » Medical News Today - Diabetes » September 8, 2008

Feeds

Medical News Today - Diabetes (5 unread)

Retacrit Effective In Patients With Diabetic Nephropathy

Posted: September 8th, 2008, 4:00pm CDT

Survey Helps Identify Strategies To Address Diabetes Care And Global Economic And Social Impact Of Type 2 Diabetes

Posted: September 8th, 2008, 7:00am CDT

New Data From A Phase 3 Study Confirms Clinical Benefits Of Once-Daily Liraglutide In The Management Of Type 2 Diabetes

Posted: September 8th, 2008, 7:00am CDT

People With Diabetes Missing Out On Life Saving Medication, UK

Posted: September 8th, 2008, 6:00am CDT

Journal Of Clinical Investigation Online Early Table Of Contents: Sept. 5, 2008

Posted: September 8th, 2008, 4:00am CDT